A Study of Impact of Bacterial Blood Stream Infections (BBSI) and Antibiotic Resistance on Transplant Related Mortality (TRM) Following Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Children: A Multicenter Study

Prakash Satwani(Pediatrics and Genetics), Christopher C. Dvorak(University of California, San Francisco), Jason L. Freedman(Children's Hospital of Philadelphia), Mala K. Talekar(Children's Hospital of Philadelphia), Zhezhen Jin, Sonali Chaudhury(Northwestern University), Aliza Gardenswartz(Hackensack University Medical Center), Meghan Hayes(Lurie Children's Hospital), Jennifer Krajewski, Alicia Chang, Marc Foca(Albert Einstein College of Medicine)
Transplantation and Cellular Therapy
February 18, 2016
10.1016/j.bbmt.2015.11.689
Cited by 0

Related Papers

Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
|Gastroenterology|2020|261
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
|Transplantation and Cellular Therapy|2013|248
Endemic<i>Pseudomonas aeruginosa</i>Infection in a Neonatal Intensive Care Unit
|New England Journal of Medicine|2000|245
Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
|Transplantation and Cellular Therapy|2012|201
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease
|Transplantation and Cellular Therapy|2020|201